Search

Author/Creator Falb, Rina

1. Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. (May 2021)

Authors:
Achiron, Anat; Mandel, Mathilda; Dreyer-Alster, Sapir; Harari, Gil; Magalashvili, David; Sonis, Polina; Dolev, Mark; Menascu, Shay; Flechter, Shlomo; Falb, Rina; Gurevich, Michael
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. (May 2021)

Authors:
Achiron, Anat; Dolev, Mark; Menascu, Shay; Zohar, Daniela-Noa; Dreyer-Alster, Sapir; Miron, Shmuel; Shirbint, Emanuel; Magalashvili, David; Flechter, Shlomo; Givon, Uri; Guber, Diana; Stern, Yael; Polliack, Michael; Falb, Rina; Gurevich, Michael
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 6(2021)
Page Start:
864
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. (April 2021)

Authors:
Achiron, Anat; Mandel, Mathilda; Dreyer-Alster, Sapir; Harari, Gil; Magalashvili, David; Sonis, Polina; Dolev, Mark; Menascu, Shay; Flechter, Shlomo; Falb, Rina; Gurevich, Michael
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗